Quinn Opportunity Partners’s Kite Pharma, Inc. KITE Stock Holding History
Bought
Maintained
Sold
Quinn Opportunity Partners's KITE Position: Q4 2017 in Review
Quinn Opportunity Partners sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 26,000 shares — an estimated $4.67M sold.
Quinn Opportunity Partners first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $4.67M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.
- Quinn Opportunity Partners reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
- Quinn Opportunity Partners sold 26,000 Kite Pharma, Inc. shares in Q4 2017, an estimated $4.67M.
- Quinn Opportunity Partners first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
- Quinn Opportunity Partners's Kite Pharma, Inc. position peaked at $4.67M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.
Based on Quinn Opportunity Partners's 13F filing for Q4 2017, filed 13 Feb 2018.